Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
RESEARCH-USE NOTICE
The innovation of self-assembled peptides has been proven to demonstrate high biocompatibility and biological activities, making them attractive as therapeutic drugs [160]
By clearing these cells, FOXO4-DRI reduces inflammation and restores tissue function, potentially mitigating age-related decline and promoting healthier aging
Tirzepatide is FDA-approved (for diabetes and weight loss, depending on the brand) and works as a dual-agonist, targeting GLP-1 and GIP receptors to reduce appetite, improve insulin response, and support weight loss
In later stages, heightened central nervous system inflammation fuels disease progression and exacerbates BBB dysfunction, with heightened levels of enzymes like MMP-9 exacerbating this breakdown
US$ 21.34
US$ 26.83
US$ 20.74
